Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04307004 · ClinicalTrials.gov registry record · NA

Evaluating Novel Approaches for Estimating Awake and Sleep Blood Pressure

A NA study of Blood Pressure, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
654
Enrollment target
2
Study locations

NCT04307004 is a NA study of Blood Pressure that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 654 participants, above the 280-participant average among 101 other Blood Pressure trials with a reported enrollment target (134% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04307004, a NA study of Blood Pressure, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
654 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the proposed study is to test whether measuring unattended blood pressure using an automated blood pressure monitor in a clinic setting without staff being present can reduce the need for assessing out-of- clinic awake blood pressure using ambulatory monitoring. Also, the investigators will test whether asleep blood pressure can be accurately measured using a novel home blood pressure monitoring device with less burden compared with ambulatory monitoring.

Conditions Studied

Interventions

  • OTHER Unattended blood pressure measurement
  • OTHER Attended blood pressure measurement
  • OTHER Ambulatory blood pressure monitoring
  • OTHER Home blood pressure monitoring

Study Locations (2)

Alabama

  • University of Alabama at Birmingham Hypertension Research Clinic - Birmingham

New York

  • Columbia University Medical Center - Hypertension Center - New York

Trial Details

FieldValue
Enrollment Target 654 participants
Start Date 2019-07-15
Est. Completion 2022-12-13
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04307004

The ClinicalTrials.gov registry entry for NCT04307004 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 654 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 280-participant average among 101 other Blood Pressure trials with a reported enrollment target (134% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 4 interventions - of which Unattended blood pressure measurement is the first listed.

NCT04307004 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, New York.

Frequently Asked Questions

What is clinical trial NCT04307004 about?

NCT04307004 is a clinical study titled "Evaluating Novel Approaches for Estimating Awake and Sleep Blood Pressure". The purpose of the proposed study is to test whether measuring unattended blood pressure using an automated blood pressure monitor in a clinic setting without staff being present can reduce the need for assessing out-of- clinic awake blood pressure using ambulatory monitoring. Also, the investigator...

What is the current status of trial NCT04307004?

This trial is currently completed. It is a NA study. The enrollment target is 654 participants. The study started on 2019-07-15. Estimated completion is 2022-12-13.

What conditions does trial NCT04307004 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT04307004?

The interventions under investigation include: Unattended blood pressure measurement (OTHER), Attended blood pressure measurement (OTHER), Ambulatory blood pressure monitoring (OTHER), Home blood pressure monitoring (OTHER).

Who is sponsoring clinical trial NCT04307004?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04307004 being conducted?

This trial has 2 study locations across Alabama, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.